These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 26791875

  • 1. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ, Kelder JC.
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [Abstract] [Full Text] [Related]

  • 2. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ, Kelder JC.
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [Abstract] [Full Text] [Related]

  • 3. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y, Wang YF, Wang KL, Lv FF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun 18; 46(3):478-82. PubMed ID: 24943033
    [Abstract] [Full Text] [Related]

  • 4. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ, Kelder JC.
    Clin Exp Rheumatol; 2014 Jun 18; 32(3):349-53. PubMed ID: 24529195
    [Abstract] [Full Text] [Related]

  • 5. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J, Papasidero S, Medina MA, Klajn D, Chaparro Del Moral R, Rillo O, Martiré V, Crespo G, Secco A, Catalan Pellet A, Amitrano C, Crow C, Asnal C, Pucci P, Caeiro F, Benzanquen N, Pirola JP, Mayer M, Zazzetti F, Velez S, Barreira J, Tamborenea N, Santiago L, Raiti L.
    Clin Rheumatol; 2017 Nov 18; 36(11):2455-2460. PubMed ID: 28913747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    Mohammed K, Pope J, Le Riche N, Brintnell W, Cairns E, Coles R, Bell DA.
    J Rheumatol; 2009 Sep 18; 36(9):1937-42. PubMed ID: 19487261
    [Abstract] [Full Text] [Related]

  • 9. Is extra-glandular organ damage in primary Sjögren's syndrome related to the presence of systemic auto-antibodies and/or hypergammaglobulinemia? A long-term cohort study with 110 patients from the Netherlands.
    Ter Borg EJ, Kelder JC.
    Int J Rheum Dis; 2017 Jul 18; 20(7):875-881. PubMed ID: 28447402
    [Abstract] [Full Text] [Related]

  • 10. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R, Nyhagen C, Tabery H, Theander E.
    Ann Rheum Dis; 2000 Jan 18; 59(1):54-60. PubMed ID: 10627428
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A, Daien C, Nutz A, Bollore K, Bedin AS, Morel J, Zimmermann V, Nocturne G, Peries M, Guigue N, Gottenberg JE, Van de Perre P, Mariette X, Tuaillon E.
    Front Immunol; 2019 Jan 18; 10():1153. PubMed ID: 31191532
    [Abstract] [Full Text] [Related]

  • 13. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C, Mosca M, Della Rossa A, Pepe P, Notarstefano C, Ferro F, Luciano N, Talarico R, Tani C, Tavoni AG, Bombardieri S.
    Clin Exp Rheumatol; 2013 Jan 18; 31(2):272-80. PubMed ID: 23343785
    [Abstract] [Full Text] [Related]

  • 14. Primary Sjogren's syndrome: current and prospective therapies.
    Thanou-Stavraki A, James JA.
    Semin Arthritis Rheum; 2008 Apr 18; 37(5):273-92. PubMed ID: 17714766
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
    Haga HJ, Andersen DT, Peen E.
    Clin Rheumatol; 2011 Mar 18; 30(3):369-72. PubMed ID: 21234630
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody].
    Han YJ, Li CH, Chen XY, Zhao JX.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):1000-1006. PubMed ID: 38101780
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IgA rheumatoid factor in primary Sjogren's syndrome.
    Peen E, Mellbye OJ, Haga HJ.
    Scand J Rheumatol; 2009 Dec 18; 38(1):46-9. PubMed ID: 18942022
    [Abstract] [Full Text] [Related]

  • 19. The findings of musculoskeletal ultrasonography on primary Sjögren's syndrome patients in childhood with articular manifestations and the impact of anti-cyclic citrullinated peptide antibody.
    Shabana K, Okamoto N, Sugita Y, Shindo K, Murata T, Tamai H, Fujiwara K.
    Mod Rheumatol; 2019 Sep 18; 29(5):821-828. PubMed ID: 30289018
    [Abstract] [Full Text] [Related]

  • 20. Primary Sjögren's syndrome.
    Bowman SJ.
    Lupus; 2018 Oct 18; 27(1_suppl):32-35. PubMed ID: 30452329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.